Endobloc Tablet (Ambrisentan) | Helps Manage Pulmonary Arterial Hypertension

In stock
SKU
PR001
Rating:
80% of 100
$0.00

Endobloc Tablet contains Ambrisentan, a medicine used to treat Pulmonary Arterial Hypertension (PAH). It helps lower blood pressure in the lungs, improves exercise capacity, and slows disease progression. 

Read More

Endobloc 5 Tablet (Ambrisentan 5mg)

PackageQTYPriceAdd To Cart
30 Tablet/s $192.09
60 Tablet/s $304.18
90 Tablet/s $576.27

Endobloc 10 Tablet (Ambrisentan 10mg)

PackageQTYPriceAdd To Cart
30 Tablet/s $314.22
60 Tablet/s $628.44
90 Tablet/s $942.66

Product Overview

Endobloc Tablet is a cardiovascular medication specifically developed for the management of pulmonary arterial hypertension (PAH). Containing the potent active compound Ambrisentan, this advanced therapeutic agent is designed to target high blood pressure within the specialized arteries connecting the heart to the lungs. By alleviating vascular constriction, Endobloc helps reduce the intensive workload placed on the right ventricle of the heart, effectively delaying disease progression and enhancing overall functional capacity. This clinical-grade formulation serves as a core treatment strategy to restore standard exercise tolerance, relieve breathing distress, and significantly improve the daily quality of life for individuals diagnosed with World Health Organization (WHO) Functional Class II or III pulmonary hypertension.

Product Composition

  • Active Therapeutic Agent: Ambrisentan (available in 5mg and 10mg strengths)
  • Tablet Formulation: Film-coated, solid oral dosage form optimized for steady systemic absorption
  • Core Excipients: Formulated with standard pharmaceutical binders, including lactose monohydrate and microcrystalline cellulose

Product Specification

Parameter Details
Brand Name Endobloc
Active Ingredient Ambrisentan
Therapeutic Class Endothelin Receptor Antagonists (ERAs)
Available Strengths 5mg / 10mg Tablets
Primary Indication WHO Functional Class II and III Pulmonary Arterial Hypertension

 

Mechanism of Action

  • Selective Receptor Antagonism: The active compound functions by specifically targeting and binding to endothelin type-A (ETA) receptors found on vascular smooth muscle cells.
  • Blocking Vascular Constriction: It directly prevents endothelin-1—a natural peptide produced by the body—from causing harmful narrowing and thickening of the pulmonary blood vessels.
  • Vasodilation and Cardiac Relief: By blocking this chemical pathway, the medication promotes significant relaxation and widening of the lung arteries, which lowers pulmonary vascular resistance and allows the heart to pump blood with less effort.

Key Benefits

  • Clinically proven to enhance exercise capacity and daily stamina, allowing individuals to walk longer distances without experiencing debilitating fatigue.
  • Significantly delays the risks associated with clinical worsening and reduces the frequency of emergency hospitalization related to PAH symptoms.
  • Effectively diminishes severe respiratory discomfort, making breathing smoother and more manageable during standard physical activities.
  • Works exceptionally well as an upfront dual-therapy option when combined with phosphodiesterase-5 inhibitors like tadalafil to optimize vascular dilation.

Precautions

Important Precautions for Endobloc Tablet (Ambrisentan)

Endobloc Tablet helps in managing pulmonary arterial hypertension (PAH). Use it carefully under proper guidance to ensure safe and effective results.

Precaution Area Details
Liver Function May affect liver. Regular monitoring is needed.
Pregnancy Can harm unborn baby. Avoid use during pregnancy.
Breastfeeding Not recommended while breastfeeding.
Blood Pressure May lower blood pressure. Monitor regularly.
Fluid Retention Can cause swelling in feet or ankles.
Anaemia Risk May reduce haemoglobin levels. Check blood tests.
Allergic Reaction Avoid if allergic to Ambrisentan.
 

 

Important Safety Advice

  • Take regular blood tests as advised
  • Inform about all ongoing medicines
  • Do not skip or change dose without guidance
  • Report swelling, dizziness, or breathing issues

When to Avoid Endobloc Tablet

  • Severe liver disease
  • Pregnancy or planning pregnancy
  • Known allergy to Ambrisentan

Monitoring Requirements

  • Liver function tests
  • Haemoglobin levels
  • Blood pressure checks
  • Regular clinical follow-up for PAH management

Usage

This advanced oral medication requires careful medical monitoring to ensure safe and effective long-term management of pulmonary blood pressure. Patients must maintain a strict daily routine and undergo baseline liver function and hemoglobin assessments before starting the therapy. It is vital to continue taking the tablets exactly as prescribed by a cardiologist, even if physical stamina and breathing comfort begin to show significant improvement.

Parameter Clinical Guidelines
Standard Dosage The typical starting dose is 5mg taken once daily, which may be increased to 10mg once daily based on individual tolerance and clinical response.
Administration Route For oral use only. Swallow the film-coated tablet completely whole with a glass of water, and do not crush, split, or chew it.
Timing and Food Can be administered safely with or without food. Take the tablet at the exact same time every day to maintain steady therapeutic drug levels.
Special Monitoring Female patients of childbearing potential must complete a negative pregnancy test before initiation and repeat testing monthly during treatment.

Uses

  • Management of Pulmonary Hypertension: Indicated specifically to treat WHO Functional Class II or III pulmonary arterial hypertension to improve exercise capacity.

  • Preventing Disease Progression: Prescribed to delay the clinical worsening of vascular symptoms and lower the risk of emergency PAH hospitalization.

  • Combination Therapy: Utilized as a core component in combination treatment regimens alongside phosphodiesterase inhibitors to maximize lung artery dilation.

Side Effects

Possible Side Effects of Endobloc Tablet (Ambrisentan)

Endobloc Tablet (Ambrisentan) used for pulmonary arterial hypertension (PAH) may cause some side effects. Not everyone experiences them, and many are mild and manageable.

Side Effect Type Details
Common Effects Headache, flushing, dizziness.
Fluid Retention Swelling in ankles or legs.
Blood Changes Low haemoglobin levels may occur.
Respiratory Nasal congestion or sinus discomfort.
Gastrointestinal Nausea or stomach discomfort.
Liver Effects Possible liver enzyme changes.
 

 

Common Side Effects

  • Headache
  • Dizziness
  • Flushing of face
  • Swelling in legs or ankles

Less Common But Important Effects

  • Shortness of breath worsening
  • Unusual tiredness
  • Signs of anaemia like weakness
  • Abnormal liver function tests

When to Seek Attention

  • Severe swelling or rapid weight gain
  • Yellowing of skin or eyes
  • Persistent fatigue or weakness
  • Breathing difficulty worsening

General Note

  • Regular monitoring helps reduce risks
  • Report any unusual symptoms early
  • Do not ignore persistent side effects

FAQs

Q: What is Endobloc Tablet used for?

A: This medicine treats pulmonary arterial hypertension. It lowers high blood pressure in the lung blood vessels to improve breathing and boost physical stamina.

Q: How does Ambrisentan work to lower lung blood pressure?

A: It belongs to a class called endothelin receptor antagonists. The drug relaxes and widens lung arteries by blocking a natural peptide that causes blood vessels to narrow. This reduces the strain on your heart.

Q: Can Endobloc Tablets be taken during pregnancy?

A: No, this medication is strictly contraindicated during pregnancy because it can cause serious birth defects. Women must undergo regular pregnancy tests and use reliable contraception during treatment.

Q: What should I do if I miss a daily dose?

A: Take it as soon as you remember on that day. If your next scheduled dose is near, skip the missed one. Never take two tablets together to make up for a missed dose.

Q: Are there any specific food restrictions with this medication?

A: You can take this tablet with or without food. Swallow the tablet whole with water at the same time each day to keep drug levels stable.

Q: What are the most common side effects of this treatment?

A: Common side effects include fluid retention with swelling in the ankles or legs, nasal congestion, headache, and skin flushing. Report any sudden or severe swelling to your doctor immediately.

Interactions

Drug Interactions of Endobloc Tablet (Ambrisentan)

Endobloc Tablet (Ambrisentan) may interact with certain medicines, affecting its effectiveness or increasing side effects. Always share your full medicine history before starting treatment.

Medicine or Class Interaction Details
Cyclosporine Can increase Ambrisentan levels in blood.
Rifampicin May reduce effectiveness of Endobloc Tablet.
Antiretroviral medicines May alter drug concentration.
Other PAH medicines May increase risk of low blood pressure.
Blood pressure medicines Can cause excessive drop in blood pressure.
Strong liver affecting drugs May increase liver-related risks.
 

Important Interaction Warnings

  • Avoid combining with multiple pulmonary hypertension therapies without guidance
  • Monitor blood pressure regularly when used with antihypertensives
  • Liver enzyme changes may occur with interacting drugs
  • Dose adjustments may be needed in certain combinations

Other Considerations

  • Inform about all prescription and non-prescription medicines
  • Include herbal supplements in interaction check
  • Avoid self-adjusting dose when starting or stopping any medicine
  • Regular monitoring is essential during combined therapy
More Information
Manufacturer:Cipla Pharma, India
Trade Name:Letairis
Generic Search:Ambrisentan
Strength:5 mg, 10mg
Write Your Own Review
You're reviewing:Endobloc Tablet (Ambrisentan) | Helps Manage Pulmonary Arterial Hypertension
Your Rating